Cargando…
A modelling framework for improved design and decision-making in drug development
The development of a new drug is an extremely high-risk enterprise. The attrition rates of development projects and the average costs for each launched product are daunting, and the completion of a development program requires a very long time horizon. These facts imply that there are huge potential...
Autor principal: | Wiklund, Stig Johan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6713335/ https://www.ncbi.nlm.nih.gov/pubmed/31461440 http://dx.doi.org/10.1371/journal.pone.0220812 |
Ejemplares similares
-
Selection bias, investment decisions and treatment effect distributions
por: Wiklund, Stig Johan, et al.
Publicado: (2021) -
Strategic larval decision-making in a bivoltine butterfly
por: Friberg, Magne, et al.
Publicado: (2012) -
Development of multi-criteria decision analysis (MCDA) framework for off-patent pharmaceuticals – an application on improving tender decision making in Indonesia
por: Inotai, Andras, et al.
Publicado: (2018) -
A Framework for Clinicians to Improve the Decision-Making Process in Return to Sport
por: Yung, Kate K., et al.
Publicado: (2022) -
A Framework for Measurement Feedback to Improve Decision-Making in Mental Health
por: Seidman, Edward, et al.
Publicado: (2009)